EUR-Lex Search results

Back to EUR-Lex homepage

This document is an excerpt from the EUR-Lex website

Search Results

Sort by

Written question E-004958/14 Mara Bizzotto (EFD) to the Commission. The scandal of thalidomide and justice for the European survivors

CELEX number:
92014E004958
Form:
Written question
Author:
European Parliament, Not available
Date of document:
16/04/2014; Date of transmission
Number of pages:
2

Written question E-003477/14 Charles Tannock (ECR) to the Commission. Legal status of experiments on primates

CELEX number:
92014E003477
Form:
Written question
Author:
European Parliament, Not available
Date of document:
21/03/2014; Date of transmission
Number of pages:
1

Written question E-002557/14 Hiltrud Breyer (Verts/ALE) to the Commission. Old pharmaceuticals and their impact on the environment

CELEX number:
92014E002557
Form:
Written question
Author:
European Parliament, Not available
Date of document:
05/03/2014; Date of transmission
Number of pages:
2

Written question P-002555/14 Françoise Grossetête (PPE) to the Commission. Food supplements/medical devices

CELEX number:
92014E002555
Form:
Written question
Author:
European Parliament, Not available
Date of document:
05/03/2014; Date of transmission
Number of pages:
2

Written question E-002359/14 Sergio Paolo Francesco Silvestris (PPE) and Oreste Rossi (PPE) to the Commission. New discovery on the properties of acetic acid in the treatment of tuberculosis (TBC)

CELEX number:
92014E002359
Form:
Written question
Author:
European Parliament, Not available
Date of document:
28/02/2014; Date of transmission
Number of pages:
2

Written question E-001974/14 Hiltrud Breyer (Verts/ALE) to the Commission. Ppharma and collection schemes for unused pharmaceuticals

CELEX number:
92014E001974
Form:
Written question
Author:
European Parliament, Not available
Date of document:
20/02/2014; Date of transmission
Number of pages:
2

Written question E-001886/14 Othmar Karas (PPE) and Paul Rübig (PPE) to the Commission. Strategy for the pharmaceutical industry and pricing in the internal market

CELEX number:
92014E001886
Form:
Written question
Author:
European Parliament, Not available
Date of document:
19/02/2014; Date of transmission
Number of pages:
2

Written question E-001887/14 Antigoni Papadopoulou (S&D) to the Commission. Prices of medicines in Cyprus

CELEX number:
92014E001887
Form:
Written question
Author:
European Parliament, Not available
Date of document:
19/02/2014; Date of transmission
Number of pages:
2

Written question E-001827/14 Christofer Fjellner (PPE) to the Commission. EU-Canada Comprehensive Economic and Trade Agreement: levelling the playing field for the life sciences industry

CELEX number:
92014E001827
Form:
Written question
Author:
European Parliament, Not available
Date of document:
18/02/2014; Date of transmission
Number of pages:
2

Written question E-000914/14 Sergio Paolo Francesco Silvestris (PPE) to the Commission. Health risks associated with using a mouthwash

CELEX number:
92014E000914
Form:
Written question
Author:
European Parliament, Not available
Date of document:
29/01/2014; Date of transmission
Number of pages:
3
Sort by
2
Domain: All, EUROVOC descriptor: pharmaceutical product, Form: Written question, Search language: English